Penumbra Inc. (PEN)
BMV
Closed
Oct 7, 2026
Day's Range
4,775.7052 wk Range
4,775.70Overview - PEN - Penumbra Inc.
Key Statistics
Valuation
Enterprise Value
3.40T
P/E (Trailing)
‪57.95‬
PEG Ratio
‪-2.46‬
Price / Sales (TTM)
‪125.00‬
Price / Book
‪7.00‬
EV / EBITDA
‪918.66‬
Profitability
Gross Margin
‪67.92%‬
Profit Margin
‪10.67%‬
Operating Margin
‪10.52%‬
Return on Assets
‪6.41%‬
Return on Equity
‪11.37%‬
Ownership
Shares Outstanding
39.38M
Float
38.27M
Held by Insiders
‪2.89%‬
Held by Institutions
‪88.33%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪4,775.70‬
200-Day Avg
‪4,775.70‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - PEN - Penumbra Inc.
Peers - PEN - Penumbra Inc.
Peer Comparison
Compared with companies in Medical Devices listed on BMV.
- PENBMVPenumbra Inc.188.11BMarket Cap+0.00%52-week change57.96P/E (Trailing)‪10.67%‬Profit Margin
- CVXBMVChevron Corporation7.27TMarket Cap+23.33%52-week change20.29P/E (Trailing)‪9.83%‬Profit Margin
- SUNBMVSchneider Electric SE3.26TMarket Cap+9.73%52-week change34.54P/E (Trailing)‪11.27%‬Profit Margin
- ABTBMVAbbott Laboratories3.05TMarket Cap-37.45%52-week change31.66P/E (Trailing)‪11.64%‬Profit Margin
- MDTNBMVMedtronic plc2.02TMarket Cap-8.62%52-week change22.57P/E (Trailing)‪13.93%‬Profit Margin
- SYKBMVStryker Corp.1.82TMarket Cap-42.94%52-week change28.09P/E (Trailing)‪14.43%‬Profit Margin
- ICEBMVIntercontinental Exchange, Inc.1.50TMarket Cap-20.53%52-week change21.23P/E (Trailing)‪38.24%‬Profit Margin
Profile Summary - PEN - Penumbra Inc.
About
Penumbra Inc. is a medical device company that designs, develops, manufactures, and markets products for interventional therapies in vascular and neurological care. Its portfolio centers on thrombectomy systems used to remove blood clots, including solutions for peripheral and neurovascular applications, along with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
